4.5 Review

Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 118, Issue 3, Pages 317-325

Publisher

WILEY
DOI: 10.1111/j.1471-4159.2011.07314.x

Keywords

Alzheimer's disease; Huntington's disease; macroautophagy; mitophagy; Parkinson's disease

Funding

  1. Research Grants Council of Hong Kong [HKUST 661007, 661109, 660309, 660210, 1/06C, 6/CRF/08]
  2. University Grants Committee [AoE/B-15/01]

Ask authors/readers for more resources

Autophagy is an evolutionarily conserved homeostatic process for the turnover of cellular contents, organelles and misfolded proteins through the lysosomal machinery. Recently, the involvement of autophagy in the pathophysiology of neurodegenerative diseases has attracted considerable interest because autophagy deregulation has been linked to some of these neurodegenerative disorders. This interest is further heightened by the demonstration that various autophagic pathways, including macroautophagy and chaperone-mediated autophagy, are implicated in the turnover of proteins that are prone to aggregation in cellular or animal disease models. These observations have stimulated new awareness in the pivotal role of the autophagic pathways in neurodegenerative disease pathophysiology, and have sparked extensive research aimed at deciphering the mechanisms by which autophagy is altered in these disorders. Here, we summarize the latest advances in our understanding of the role of autophagy deregulation in Parkinson's, Alzheimer's and Huntington's disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available